Skip to content

Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery

Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02009072
Enrollment
150
Registered
2013-12-11
Start date
2010-04-30
Completion date
2012-11-30
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pterygium

Keywords

Pterygium surgery, Sutureless glue free conjunctival autograft, Amniotic membrane graft.

Brief summary

Pterygium is a common ocular pathology facing ophthalmologists that has varied surgical management techniques and high rate of post-operative recurrence. The investigators aim was to compare and evaluate the safety and efficacy outcomes of those two surgical procedures in management of primary pterygium.

Detailed description

Design: Prospective randomized clinical trial comparative study. Setting: Department of ophthalmology, Al-Minia University Faculty of medicine, Egypt. Methods: The study included 150 eyes of 150 patients of primary pterygium. Twenty four to 74 years of age (mean 49 ± 12 years). Simple excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1), versus sutured free conjunctival autograft in 100 eyes of 100 patients (group 2).

Interventions

PROCEDURESutureless and glue free limbal conjunctival autograft

Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1)

PROCEDURESutured limbal conjunctival autograft

Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutured limbal conjunctival autograft in 100 eyes of 100 patients (group 2).

Sponsors

Minia University
CollaboratorOTHER
Shaaban Elwan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
24 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

Patients complaining of primary pterygium with eye redness. Patients with pterygium threatening the visual axis.

Exclusion criteria

All cases not completed the follow up period for two years. Atrophic pterygium, pseudopterygium or double head pterygium.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence Rate24 monthsThe main postoperative primary outcomes measure the recurrence rate which was defined as fibrovascular proliferation invading the cornea more than 1.5 mm at the site of previously excised pterygium.

Secondary

MeasureTime frameDescription
Postoperative signs and symptomsThird postoperative day,then weekly for one monthThe secondary outcomes measure, postoperative pain, foreign body sensation, photophobia, hyperemia and chemosis.
Overall patient satisfactionThird post-operative weekOverall satisfaction with the procedure 3 weeks post-operatively was recorded as four grades 0= unsatisfied, 1= low satisfaction, 2= moderate satisfaction and 3= highly satisfied, the data were collected as mean scores and recorded. The two groups were compared for overall satisfaction.
Complications24 monthsComplications was recorded including, persistent epithelial defect, dellen, inclusion cyst, pyogenic granuloma, conjunctival edema, corneal scleral necrosis, infective scleritis, keratitis and endophthalmitis.

Other

MeasureTime frameDescription
Operative timeIntraoperativeCalculation of operative time for each patient procedure
Gain in uncorrected visual acuity (UCVA)First post-operative monthGain in uncorrected visual acuity (UCVA) for each patient from the base line measurement

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026